01. Armstrong GL, Wasley A, Simard EP et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
Ann Intern Med. 2006;144:705-14.

02. Chak E, Talal A, Sherman K et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver international. 2011;31:1090-101.

03. CDC 2012 Surveillance. Available at:http://www.cdc.gov/hepatitis/Statistics/2012Surveillance/Commentary.htm#hepC. Accessed 10/8/14.

04. CDC. National hepatitis C prevention strategy: a comprehensive strategy for the prevention and control of hepatitis C virus infection and its consequences. 2001.

05. Ly KN, Xing J, Klevens M. et al. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007.
Ann Intern Med. 2012;156:271-278,317-318.

06. Sanyal AJ. The Institute of Medicine report on viral hepatitis: a call to action. Hepatology. 2010; 51:727-728.

07. McHutchison JG, Bacon BR. Chronic hepatitis C: an age wave of disease burden. Am J Manag Care. 2005;11(10 Suppl):S286-95; quiz S307-11.

08. Rein DB, Wittenborn JS, Weinbaum CM et al. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis. 2011;43:66-72.

09. Pyensan B, Ritch K, Iwasake K. Consequences of hepatitis C virus (HCV): Costs of a baby boomer epidemic of liver disease. Available at http://publications.milliman.com/research/health-rr/pdfs/consequences-hepatitis-cvirus-RR05-18-09.pdf Accessed 10/8/14

10. Hepatitis C Information for Health Professionals. Available at: http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm. Accessed 10/8/14

11. Colvin HM, Mitchell AE. Hepatitis and liver cancer: A national strategy for prevention and control of hepatitis B and C. Washington, DC: The National Academies Press; 2010.

12. Alberti A, Vario A, Ferrari A et al. Review article: chronic hepatitis C - natural history and Cofactors.
Aliment Pharmacol Ther 2005;22(Suppl 2):74-78.

13. Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am 2009;93:931-950.

14. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm. Accessed 10/8/14.

15. Recommendations for Testing, Managing, and Treating Hepatitis C. AASLD. Available at http://www.hcvguidelines.org/full-report. Accessed 10/8/14.

16. Orasure Technologies, Inc. OraQuick® HCV Rapid Antibody Test. Updated April 26, 2011.
http://www.orasure.com/products-infectious/products-infectious-oraquick-hcv.asp. Accessed 10/8/14.

17. Olysio® package insert. Titusville, NJ: Janssen Products; 2013.

18. Sovaldi® package insert. Foster City, CA: Gilead Sciences, Inc; 2013.

19. Harvani® package insert. Foster City, CA: Gilead Sciences, Inc; 2014.